Eli Lilly Vs. Novo Nordisk: Which Stock Could Lead Pharma's 2026 Comeback

As investors look beyond mega-cap tech for the next leg of growth, pharma is quietly moving back into focus — and no two names capture that shift better than Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) .Track LLY stock here.GLP-1 Demand Is Becoming StructuralThe obesity and diabetes drug boom is no longer a one-cycle story. Demand for GLP-1 treatments continues to exceed supply, with physicians expanding use beyond diabetes into weight management and cardiovascular risk reduction.That long-t ...